A widespread recognition that much of current medical practice does not have a strong evidentiary base has led to funding for comparative effectiveness research (CER) under the American Reinvestment and Recovery Act (ARRA) in 2009 and creation of the Patient-Centered Outcomes Research Institute (PCORI) through the Patient Protection and Affordable Care Act (PPACA) in 2010.

In this talk, Dr. Basu will discuss some of the fundamental issues that exist surrounding the economics of information and behavior in the health care sector and whether CER can help address these problems. Dr. Basu will highlight the need to individualize comparative effectiveness research in order to achieve the goals set out by the CER agenda. Dr. Basu will discuss methodological principles that guide research designs for such studies and present several examples to motivate these discussions.


Dr. Basu is an associate professor in the Departments of Health Services and Pharmacy at the University of Washington, Seattle. He is also a faculty research fellow at the National Bureau of Economic Research. Dr. Basu's research interests lie in revealing heterogeneity in clinical and economic outcomes in order to establish the value of individualized care. His work has focused on translating such information for public policy using innovative methods in comparative effectiveness and cost effectiveness research.

Dr. Basu is an Associate Editor for both Health Economics and the Journal of Health Economics and has taught courses on decision analysis, cost effectiveness analysis, and health services research methods. He has received numerous recognitions for his work throughout his career, for which he remains grateful to his mentors and peers: the NARSAD Wodecroft Young Investigator Award (2005), the Research Excellence Award for Methodological Excellence (2007), the Bernie O’Brien New Investigator Award (2009) from the International Society for Pharmacoeconomics and Outcomes Research, the Alan Williams Health Economics Fellowship (2008) from the University of York, UK, and the Labelle Lectureship in Health Economics (2009) from McMaster University, Canada.